Quantum X Labs (Nasdaq: QXL) rebrands after acquisition into quantum tech
Rhea-AI Filing Summary
Quantum X Labs Inc., formerly Viewbix Inc., has changed its corporate name and Nasdaq trading symbol. Effective April 30, 2026, the company’s name became Quantum X Labs Inc. and its ticker switched from VBIX to QXL, with related charter and bylaw amendments limited to the new name.
The company states that the name change and symbol change do not affect security holders’ rights, and existing stock certificates remain valid. A concurrent press release highlights a broader rebranding toward quantum computing, quantum error correction, simulations, and quantum sensing, while maintaining its legacy digital advertising and AI-driven software businesses.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Certificate of Amendment regulatory
Amended and Restated Bylaws regulatory
quantum error correction technical
emerging growth company regulatory
Private Securities Litigation Reform Act of 1995 regulatory
forward-looking statements financial
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of report (date of earliest event reported):
QUANTUM X LABS INC.
(Exact Name of Registrant as Specified in its Charter)
Commission
File No.:
| (State of Incorporation) | (I.R.S. Employer Identification No.) |
| (Address of Registrant’s Office) | (ZIP Code) |
Registrant’s
Telephone Number, including area code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
Effective at 12:01 a.m. (Eastern Time) on April 30, 2026, Viewbix Inc., a Delaware corporation (the “Company”), changed its name from “Viewbix Inc.” to “Quantum X Labs Inc.” (the “Name Change”) by filing a Certificate of Amendment (the “Certificate of Amendment”) to its Certificate of Incorporation, as amended (the “Certificate of Incorporation”), with the Secretary of State of the State of Delaware on April 29, 2026.
In accordance with the General Corporation Law of the State of Delaware (the “DGCL”), the board of directors of the Company (the “Board”) approved the Name Change and the Certificate of Amendment. Pursuant to Section 242 of the DGCL, stockholder approval was not required in connection with the Name Change or the Certificate of Amendment.
In addition, the Board approved a change of the Company’s trading symbol from “VBIX” to “QXL” on The Nasdaq Capital Market (the “Symbol Change”).
In connection with the Name Change, effective April 30, 2026, the Company amended and restated its Amended and Restated Bylaws (the “Bylaws”) to reflect the Name Change (the “A&R Bylaws”). The A&R Bylaws contain no other changes. In accordance with the DGCL and the Bylaws, the Board approved the A&R Bylaws, and stockholder approval was not required for such amendment.
There were no other changes to the Certificate of Incorporation or the Bylaws except as disclosed in this Current Report on Form 8-K.
The foregoing descriptions of the Certificate of Amendment and the A&R Bylaws are qualified in their entirety by reference to the full text thereof, copies of which are filed as Exhibits 3.1 and 3.2, respectively, to this Current Report on Form 8-K and incorporated herein by reference.
Item 7.01 Regulation FD Disclosure.
On April 30, 2026, the Company issued a press release announcing the commencement of trading under its new name and trading symbol, effective as of today. A copy of the press release is furnished hereto as Exhibit 99.1 and is incorporated herein by reference.
The information in this Item 7.01, including the press release attached hereto as Exhibit 99.1, is being furnished under Item 7.01 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 8.01 Other Events.
As previously disclosed in the Company’s Current Report on Form 8-K filed on April 21, 2026, the Company initially announced the Name Change and Symbol Change in a press release dated April 21, 2026.
In connection with the Name Change and Symbol Change, the Company’s Common Stock will commence trading on The Nasdaq Capital Market under the Company’s new name, “Quantum X Labs Inc.,” and new ticker symbol “QXL,” effective at the opening of trading on April 30, 2026. The CUSIP number of the Common Stock will remain the same as a result of the foregoing.
The Name Change and Symbol Change do not affect the rights of the Company’s security holders. The Common Stock will continue to be traded on The Nasdaq Capital Market. Following the Name Change, the stock certificates of the Common Stock, which reflect the former name of the Company, will continue to be valid. Certificates reflecting the Name Change will be issued in due course as old stock certificates are tendered for exchange or transfer to the Company’s transfer agent.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description | |
| 3.1 | Certificate of Amendment to Certificate of Incorporation | |
| 3.2 | Amended and Restated Bylaws | |
| 99.1 | Press Release dated April 30, 2026 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Quantum X Labs Inc. | ||
| By: | /s/ Amihay Hadad | |
| Name: | Amihay Hadad | |
| Title: | Chief Executive Officer | |
Date: April 30, 2026
Exhibit 99.1
After Successful Acquisition: Quantum X Labs Commences Trading Under New Name and New Nasdaq Ticker Symbol “QXL” Today
Tel Aviv, Israel, April 30, 2026, (GLOBE NEWSWIRE) — Quantum X Labs Inc. (Nasdaq: QXL) (“Quantum X” or the “Company”), an advanced technologies company (formerly known as Viewbix Inc. (Nasdaq: VBIX)), to commence trading today under new name and new Nasdaq symbol, following a comprehensive corporate rebranding.
The rebranding represents the Company’s evolution toward a leading company that develops and owns quantum computing technology as well as a quantum error correction solution, quantum simulations and quantum sensing technologies, while continuing its legacy digital advertising activities as a business segment.
The new name and brand aim to position Quantum X Labs as a leading company to research, develop, and potentially commercialize innovative quantum solutions across key sectors, including navigation, precision timing, quantum algorithms, quantum error correction, drug discovery, biomedicine, nuclear simulation, transportation, and quantum cyber security. At the heart of this evolution is the Company’s wholly-owned subsidiary, Quantum X Labs Ltd., which the Company acquired in March 2026. This subsidiary operates as a dynamic quantum technology company that hires top quantum experts with a robust proprietary intellectual property portfolio, including a pioneering pending patent for AI-Quantum Error Correction and an active ecosystem of portfolio companies advancing breakthrough quantum applications.
Quantum X Labs Ltd.’s portfolio companies include:
Quantum Gyro: developing quantum-based gyroscope chip technology for unjammable, high-precision navigation systems designed to operate in GPS-denied environments. Quantum Gyro is a 40%-owned subsidiary of Quantum X Labs Ltd.
Quantum Atom Accuracy: advancing next-generation atomic clocks based on novel light-modulation schemes to deliver ultra-high accuracy, robustness, and enhanced coherence for precision timing solutions. Quantum Atom Accuracy is a wholly-owned subsidiary of Nuclear Quantum.
Nuclear Quantum: progressing quantum-powered simulation algorithms targeted at nuclear and engineering industries, with recent milestones moving toward commercial engagement with leading simulation providers. Nuclear Quantum is a 40%-owned subsidiary of Quantum X Labs.
QunatumQ Security: working on protecting assets by using quantum based cyber security. QuantumQ Security is a wholly-owned subsidiary of Quantum Gyro.
Quantum Transportation: developing transformer-based quantum decoder technology for advanced quantum error correction, including cloud-deployed neural decoders and IP licensing from Ramot at Tel Aviv University, with applications in transportation and secure systems. Quantum Transportation is a 30%-owned subsidiary of Quantum X Labs.
CliniQuantum: applying quantum-enhanced methods (such as Markov Chain Monte Carlo) to drug discovery, clinical trial optimization, logistics, biomedicine, and security sectors. CliniQuantum is a 46%-owned subsidiary of Quantum X Labs.
This rebranding builds on a series of technical milestones achieved by its portfolio companies in recent months, including patent filings, prototype breakthroughs in quantum gyroscopes and atomic clocks, and progress in quantum simulation and error-correction algorithms.
While advancing its quantum innovation, the Company will continue to support its legacy business of digital advertising and AI-driven computing solutions, through its subsidiaries Gix Media Ltd. and Metagramm Software Ltd., which complement its expanding quantum portfolio.
Quantum X Labs Inc.
Quantum X Labs Inc. and its subsidiaries are focused on quantum technology, digital advertising and computing and enterprise artificial intelligence (AI) solutions. Quantum X Labs Ltd. is focused on developing and promoting quantum algorithms for the transportation, drug discovery and security segments as well as developing quantum- based GPS replacement and quantum atom accuracy solutions. Gix Media develops a variety of technological software solutions, which perform automation, optimization and monetization of internet campaigns, for the purposes of acquiring and routing internet user traffic to its customers. Metagramm is a developer of grammatical error correction software and offers tools for writing and reviewing, grammar, spelling, punctuation and style features, as well as translation and multilingual dictionaries, using artificial intelligence and machine learning technology.
For more information about Quantum X Labs, visit https://quantumxlabs.xyz/
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, the Company is using forward-looking statements when it discusses the Company’s future plans, strategies and expectations, including the research, development, and potential commercialization of innovative quantum solutions across key sectors, including computing technologies, navigation, precision timing, quantum algorithms, error correction, drug discovery, biomedicine, nuclear simulation, transportation, and quantum cyber security. Because such statements deal with future events and are based on Quantum X Labs’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release.
The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Quantum X Labs undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Quantum X Labs is not responsible for the contents of third-party websites.
Investor Relations Contacts:
Michal Efraty
Investor Relations
michal@efraty.com